Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod Kumar Maurya

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Tropica|February 24, 2018
Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case studyPramod Kumar Maurya, Swati Singh, Ashutosh Mani
Scientific Reports|March 15, 2026
A cloud server centric multifactor lightweight authentication scheme for eHealth systemsDivyanshu Gairola, Pramod Kumar Maurya, Ankush Chanda
Current Diabetes Reviews|June 15, 2022
An <i>In-Silico</i> Approach to Identify Therapeutic Target and Markers Associated with Diabetic NephropathyBhuvnesh Rai, Pramod Kumar Maurya, Medha Srivastava, et al.
Journal of Biosciences|June 11, 2019
Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomasSuriya Narayanan Murugesan, Birendra Singh Yadav, Pramod Kumar Maurya, et al.
Journal of Genomics|July 6, 2018
Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinomaSuriya Narayanan Murugesan, Birendra Singh Yadav, Pramod Kumar Maurya, et al.
Frontiers in Endocrinology|May 30, 2023
Therapeutic potential of urine exosomes derived from rats with diabetic kidney diseaseDeendayal Das Mishra, Biswajit Sahoo, Pramod Kumar Maurya, et al.
Journal of Cancer|August 19, 2017
Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic targetPramod Kumar Maurya, Alok Mishra, Birendra Singh Yadav, et al.
Pharmacognosy Magazine|November 17, 2017
Docking-based Screening of <i>Ficus religiosa</i> Phytochemicals as Inhibitors of Human Histamine H2 ReceptorAmit Chaudhary, Birendra Singh Yadav, Swati Singh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Tropica|February 24, 2018
Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case studyPramod Kumar Maurya, Swati Singh, Ashutosh Mani
Scientific Reports|March 15, 2026
A cloud server centric multifactor lightweight authentication scheme for eHealth systemsDivyanshu Gairola, Pramod Kumar Maurya, Ankush Chanda
Current Diabetes Reviews|June 15, 2022
An <i>In-Silico</i> Approach to Identify Therapeutic Target and Markers Associated with Diabetic NephropathyBhuvnesh Rai, Pramod Kumar Maurya, Medha Srivastava, et al.
Journal of Biosciences|June 11, 2019
Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomasSuriya Narayanan Murugesan, Birendra Singh Yadav, Pramod Kumar Maurya, et al.
Journal of Genomics|July 6, 2018
Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinomaSuriya Narayanan Murugesan, Birendra Singh Yadav, Pramod Kumar Maurya, et al.
Frontiers in Endocrinology|May 30, 2023
Therapeutic potential of urine exosomes derived from rats with diabetic kidney diseaseDeendayal Das Mishra, Biswajit Sahoo, Pramod Kumar Maurya, et al.
Journal of Cancer|August 19, 2017
Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic targetPramod Kumar Maurya, Alok Mishra, Birendra Singh Yadav, et al.
Pharmacognosy Magazine|November 17, 2017
Docking-based Screening of <i>Ficus religiosa</i> Phytochemicals as Inhibitors of Human Histamine H2 ReceptorAmit Chaudhary, Birendra Singh Yadav, Swati Singh, et al.
Pageof 1